SUMMARY
Myostatin (Mstn) participates in the regulation of skeletal muscle size and emerges as a regulator of muscle metabolism. We here hypothesized that lack of myostatin profoundly depresses oxidative phosphorylation dependent muscle function. For this extent, we explored
Mstn
-/-mice as a model for the constitutive absence of myostatin and AAV-mediated overexpression of myostatin propeptide as a model of myostatin blockade in adult wildtype mice. We show that muscles from Mstn -/-mice, although larger and stronger, fatigue extremely rapidly. Myostatin deficiency shifts muscle from aerobic towards anaerobic energy metabolism as evidenced by decreased mitochondrial respiration, reduced expression of PPAR transcriptional regulators, increased enolase activity, and exercise induced lactic acidosis. In consequence, constitutively reduced myostatin signaling diminishes exercise capacity, while the hypermuscular state of Mstn -/-mice increases oxygen consumption and the energy cost of running. We wondered whether these results are the mere consequence of the congenital fiber-type switch towards a glycolytic phenotype of constitutive Mstn -/-mice. Hence we over-expressed myostatin propeptide in adult mice, which did not affect fiber-type distribution, while nonetheless causing increased muscle fatigability, diminished exercise capacity and decreased Pparb/d and Pgc1a expression. In conclusion, our results suggest that myostatin endows skeletal muscle with high oxidative capacity and low fatigability, thus regulating the delicate balance between muscle mass, muscle force, energy metabolism and endurance capacity.
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INTRODUCTION
Skeletal muscle has inbuilt control mechanisms to prevent overgrowth, which are executed at least in part by secreted molecules of the transforming growth factor-β (TGF-β) family, the most important being myostatin (Mstn). Suppression of myostatin signaling stimulates muscle growth, however, the functional benefits arising from myostatin deficiency remain under debate, because the larger muscles of myostatin knockout mice lose specific force (4, 28, 34, 40) . On the other hand, a heterozygous Mstn-mutation in racing dogs (whippets) increases performance in short distance races (37) , which could be explained by a fiber-type conversion from oxidative to glycolytic phenotype. Previous work suggested that such profound fiber-type conversion in the absence of myostatin negatively alters muscle exercise behavior, fatigability and muscle mitochondrial function (6, 15, 18, 29, 39, 42) . However, a direct effect of myostatin on muscle metabolism has not yet conclusively been established despite increasing evidence for the impact of TGF-β/Smad signaling on energy homeostasis (9, 13, 32, 47) . Moreover, the question remains open, whether previously observed metabolic and functional changes are the mere consequence of congenital fiber-type conversion following constitutive lack of myostatin or whether myostatin regulates muscle metabolism directly.
Here we hypothesized myostatin to regulate oxidative phosphorylation dependent muscle function and that this would be independent of the muscle fiber-type composition. We first investigated in detail the muscle contractile, metabolic and functional characteristics of constitutive Mstn -/-mice and found a profound deficit of aerobic exercise capacity. We then compared this phenotype to the effect of myostatin blockade in adult muscle and likewise found an increased fatigability and reduced capacity for aerobic exercise following overexpression of myostatin propeptide despite an unchanged fiber-type composition. These data and the role of myostatin in the regulation of Peroxisome Proliferator-Activated Receptor (PPAR) transcriptional activators comprehensively illustrate the importance of myostatin as a pivotal factor balancing size and strength of skeletal muscle against endurance through adaptation of its energy metabolism.
RESULTS
Decreased endurance exercise capacity and voluntary locomotor activity in myostatin deficiency An index for endurance exercise capacity is the maximal oxygen uptake per body weight (VO 2 max [ml O 2 /min/kg]), which was determined by running on a treadmill at incremental speeds in a metabolic cage. Initially, the oxygen uptake is proportional to the running speed but levels off at a plateau, the so-called VO 2 max, beyond which no further increase is possi- Figure 1A ) and a similar tendency was shown for vPeak in comparison with Mstn +/+ mice (p=0.13; Figure 1B ), while heterozygous Mstn +/-mice had an intermediate phenotype. Hence, such decreased oxygen consumption in vivo parallels the decreased oxidative phosphorylation rates in vitro ( Figure 2G ). However, absolute VO 2 max
[ml/min] of Mstn -/-mice was increased by 14% (p=0.004; Figure 1C ) owing to a respective 20% and 24% increase of total and lean body mass (p<0.01; data not shown). In consequence, the energy cost of running (running economy at 13 m/min) was increased by 15% in Mstn -/-as compared to Mstn +/+ mice (p=0.01; Figure 1D ).
"Critical Speed" accurately reflects the capacity for aerobic exercise and is based on the proportional relationship between distance run and time to exhaustion at different velocities (8 Figure 1F ). This implicates a preference for glycolysis over fatty acid oxidation, which is considered to be disadvantageous for endurance exercise (46) . Figure 2A ).
Remarkably, myostatin deficient muscle, despite being about twice as strong at the beginning of the experiment (389±11 vs 233±5 mN for soleus absolute maximal tetanic force P0, as compared to Mstn +/+ mice, p<0.001), fatigued so rapidly that absolute maximal force dropped to Mstn +/+ levels after 3 min of repetitive tetanic stimulation ( Figure 2B ). This rapid force decline caused the specific force of Mstn -/-muscles to decrease from 91% at the start to 59% at the end of the fatigue protocol in comparison to Mstn +/+ muscles (p=0.04 and p<0.001 respectively; Figure 2C ), for which measurements were performed in situ to maintain blood perfusion during the stimulation protocol (data not shown).
Increased glycolysis and decreased mitochondrial respiration rates in myostatin deficiency
To investigate whether increased muscle fatigability in the absence of myostatin resulted from increased anaerobic glucose metabolism-induced muscle acidosis, we determined serum lactate levels after exhaustive treadmill exercise. In Mstn -/-mice, serum lactate was already elevated at resting state and increased disproportionately to 12.1±1.1 mmol/l at 5 min post exercise as compared to 5.1±0.4 mmol/l in controls (p<0.001; Figure 2D ). The elevated serum lactate in myostatin deficient mice concurred with an increased enzymatic activity of enolase ( Figure 2E ), a key component of glycolysis. To determine whether lactate accumulation resulted from defective oxidative phosphorylation (OXPHOS), we investigated mitochondrial respiration rates in situ for OXPHOS complexes I, II and IV. Mstn +/+ muscles revealed higher respiration rates for the predominantly oxidative soleus muscle as compared with the predominantly glycolytic EDL muscle ( Figure 2G ). Remarkably, the absence of myostatin decreased OXPHOS rates of the soleus muscle to the level of Mstn +/+ EDL muscles, and
Mstn -/-EDL further lost OXPHOS activity of up to 42% ( Figure 2G ). It is unlikely that such Figure   2H ).
Decreased expression of PPAR transcription factors in myostatin deficient muscle
We next aimed to gain insight into the molecular mechanism of the metabolic dysregulation observed in myostatin deficiency. We hypothesized that myostatin might act in a signaling cascade upstream of PPAR transcriptional regulators because inactivation of myostatin as well as of Pparβ/δ (43) both resulted in a similar loss of the oxidative phenotype. In wildtype mice, as expected, Pparb/d, Ppara and Pparg mRNA expression levels were 2-3 times higher in the predominantly oxidative soleus muscle than in the predominantly glycolytic EDL mus-cle. As predicted, PPAR mRNA levels in the soleus muscle of Mstn -/-mice ( Figure 3D ) fell to about the level seen in Mstn +/+ EDL muscle ( Figure 3E ), while in the EDL muscle of Mstn -/-mice fell below the already low values found in Mstn +/+ EDL, although this was statistically significant only for Ppara ( Figure 3E ). Together, these results suggest that myostatin may promote high oxidative metabolism in skeletal muscle via PPAR signaling.
Myostatin blockade by AAV-propeptide in adult mice increases fatigability
To determine the role of myostatin on energy dependent muscle function during adulthood, we over-expressed myostatin propeptide using AAV as expression vectors. Injection of AAV2/8-propeptide into the femoral artery led to robust transgene expression ( Figure 4A ) and slight increase of the lower leg muscle weight ( Figure 4B ). Importantly, soleus muscle fatigued more rapidly after propeptide treatment ( Figure 4D ), despite only minimal changes of absolute maximal and specific force at the start of the fatigue protocol ( Figure 4D ) and an unaltered fiber-type composition ( Figure 4C ). Interestingly, mRNA levels of Pparb/d and p=0.79). Hence we were able to show that myostatin blockade in adult wildtype mice caused a similar deficit in aerobic muscle properties as shown for Mstn -/-mice and that these effects were independent of muscle fiber-type composition.
DISCUSSION
Myostatin exerts a dual function on skeletal muscle as it limits its size while promoting oxidative properties. We here show that myostatin acts to economize muscle energy expenditure, because smaller muscle requires less oxygen during exercise. The higher OXPHOS activity and lower respiratory exchange ratio point towards increased fatty acid consumption as a preferred fuel in the presence of myostatin and suggests higher energy efficiency as compared with the energetically less efficient glycolysis in states of myostatin deficiency. The emerging property of myostatin to save fuel combined with a simultaneous increase in running endurance and maximal running velocity might explain the high conservation of myostatin during evolution and the rare occurrence of myostatin mutations. (MRS) supports our findings as the relative contribution of oxidative ATP production to total ATP turnover was reduced following repeated isometric contractions of Mstn -/-muscles, whereas the ATP cost of contraction was increased (15) . Thus, muscle strength due to myostatin deficiency comes at the cost of exercise intolerance, which is often seen in patients with mitochondrial disorders such as MELAS or MERRF syndrome (24) . Interestingly, muscle cramps are frequently observed in whippet dogs with Mstn mutation (37). Moreover, "double muscle cattle", several breeds of which have been identified to carry Mstn mutations (17, 30) , are prone to exercise induced lactic acidosis and severe rhabdomyolysis (20, 21) .
However, a number of questions result from our work. We ask, whether the observed decrease in oxidative metabolism and energy dependent muscle function might be an indirect effect and a consequence of the profound congenital fiber-type change that is typically found in the constitutive absence of myostatin. We thus blocked myostatin in adult wildtype mice using myostatin propeptide, which did not affect fiber-type composition. This is in agreement with previous studies following blockade of myostatin or its activin IIB receptor (ActRIIB) signaling (3, 11, 12, 36) . Importantly, treatment with soluble ActRIIB-Fc to block myostatin and homologues signaling factors caused an mRNA expression profile away from oxidative metabolism (41) . Supporting the hypothesis that myostatin regulates oxidative metabolism independently of muscle fiber composition, we here found that treatment with myostatin propeptide caused muscle fatigability and decreased aerobic exercise capacity.
We show that myostatin deficiency has an influence on the expression of Ppar-α/β/γ transcription factors, which control metabolic properties but not muscle mass (43, 45) . This indicates that myostatin may control the muscle oxidative phenotype notably via PPAR activity.
Indeed, downstream targets of Ppar-β such as Pgc1-α and Cox4 were down-regulated in Mstn -/-mice (26) . Furthermore, knockout of Pparb, similar to the findings in Mstn -/-mice, reduced oxidative properties of skeletal muscle (43) . Importantly, we here show, that myostatin blockade in adult mice following overexpression of myostatin propeptide also reduced expression of Pparb and Pgc1a, supporting the hypothesis that myostatin directly regulates oxidative metabolism. However, the exact molecular mechanism remains to be elucidated as yet little is known about direct molecular targets of myostatin signaling.
Interestingly, distinct but complementary effects on the metabolic profile of obese insulinresistant mice occur when Ppar-β is activated and myostatin inhibited (7). Moreover, work on myostatin-mediated effects through AMPK (23, 44, 48 ) raise a number of questions concerning mediators and signaling pathways implicated on muscular metabolic effects of myostatin. It would be of interest to substantiate these findings by an analysis of the muscle microRNA network as this was recently shown to control metabolism via nuclear receptors such as PPARs (14) .
A further question concerns the problem, whether muscle hypertrophy following lack of myostatin changes the oxidative muscle metabolism. In fact, we previously have shown that long-term exercise improved contractile and metabolic features of Mstn -/-mice, however, these improvements were associated with a loss of muscle hypertrophy (28) . These results suggest that regulation of muscle size and metabolic phenotype by myostatin are linked. It remains to be determined, however, whether the regulation of both processes can be dissociated from each other.
Can we generalize the conclusion of our work that lack or blockade of myostatin always negatively affects aerobic muscle function? It is important to note that previous work demonstrated a beneficial effect of myostatin blockade during ageing (38) . It is quite likely that my-ostatin blockade in conditions of muscle atrophy through pathological up-regulation of myostatin (e.g. in sarcopenia, cardiac and tumor cachexia), might outweigh the negative effect on muscle metabolism by far (19, 27, 49) . Similarly, myostatin blockade improved running performance in obese and insulin resistant (ob/ob) mice (7). Again, benefits on insulin signaling and glucose metabolism may largely outweigh potential negative effects on muscle oxidative metabolism, especially if combined with a Ppar-β agonist. It should be noted that treatment of adult mice under high fat diet with soluble ActRIIB did not alter fat mass and glucose metabolism (33) , whereas treatment of obese and insulin resistant mice (ob/ob) with anti-myostatin antibodies improved glucose homeostasis and glucose tolerance (7). In fact, the metabolic changes following myostatin blockade could be beneficial for patients with insulin resistance, and recently it was shown that AAV-propeptide overexpression mediated higher glucose uptake in skeletal muscle, which is likely mediated by an up-regulation of membrane glucose transporters (12). Thus, further work is required to define under which circumstances myostatin blockade could exert beneficial effects to combat insulin resistance and overweight.
In conclusion, our results suggest that myostatin increases oxidative metabolism of skeletal muscle thereby improving exercise endurance. These fundamental functions of myostatin should be taken into account when developing therapies based on myostatin blockade. Further investigations are required to answer the question whether emerging therapies based on PPAR agonists might be able to prevent adverse effects of myostatin blockade on the oxidative metabolism and exercise tolerance. [B] Blood lactate assessment during exhaustive exercise Lactate concentration was determined in blood samples (5 μl) collected from the tip of the tail using a Lactate pro LT device (Arkray Inc., Kyoto, Japan) at the time points 0 and 5 min after treadmill running-induced exhaustion. Exhaustion was defined as the time point at which mice could not run anymore and stayed on the grid despite repeated electric stimulation. The running test started at the lowest speed of 5 cm/s to allow a warm-up and was increased by 1 cm/s every 30 seconds until exhaustion.
[C] Measurement of maximal oxygen consumption (25) . The single-lane test treadmill was placed in a metabolic chamber. Ambient air was flushed through the chamber at a rate of 0.66 l/min, and gas samples were extracted to measure oxygen content (Oxymax, Columbus instrument, Columbus, OH). Gas samples were dried, measured every 15 s and oxygen consumption (VO 2 ) was calculated using Oxymax software. The gas analyzers were calibrated with standardized gas mixtures before every test session (Air Products, Paris, France), as recommended by the manufacturer. The test described below provided a measure of VO 2 max, defined as the highest oxygen consumption attained during the testing protocol.
The velocity attained by the mouse at this VO 2 max was then considered as the vVO 2 max. The maximal velocity (vPeak) was measured at the end of the test.
[D] Incremental test load
Mice were treadmill exercised on with adjustable belt speed (0-99.9 m/min) and electric shock bars (0-2 mA) at the rear of the belt to provide a stimulus encouraging each mouse to run. Over a one week period, the mice were familiarized with the treadmill through the completion of four 10 min running sessions from 0 to 9 m/min. The mice subsequently performed an incremental exercise test, without slope. The exercise intensity was increased by 3 m/min (starting from 10 m/min) every 3 min, and the exercise continued until exhaustion.
Measurement of voluntary locomotion
Total voluntary locomotor activities were determined in individual cages with bedding, food and water (Labmaster, TSE Systems GmbH). Animals were acclimated in individual cages for 48 hours before experimental measurements. Each cage was embedded in a frame with an infrared light beam-based activity monitoring system, allowing measurement of total locomotor activity. Data were collected in intervals of 40 minutes during the whole experiment and the activity level was recorded as the number of beam interruptions per 40 min. Mice had access to food and water ad libitum except for the 24 hours fasting in order to stimulate locomotor activity of mice.
Measurement of contractile properties
The contractile properties of extensor digitorum longus (EDL) and soleus muscles were studied in vitro according to previously published protocols (2 force to fall by 50% (EDL) or 30% (soleus) was then measured. All data were recorded and analyzed on a microcomputer, using the PowerLab system (4SP, AD Instruments) and software (Chart 4, ADInstruments).
The isometric contractile properties of gastrocnemius (+soleus) were studied in situ as previously described (22) . Mice were anesthetized (pentobarbitone sodium, 50 mg/kg). Supplemental doses were given as required to maintain deep anesthesia throughout the experiments. The foot was fixed with clamp and the knee was immobilized using stainless steel pins. The distal tendon of the plantaris muscle was cut. The Achilles tendon was attached to an isometric force transducer (Harvard). Great care was taken to ensure that the blood and nerve supply remained intact during surgery. The sciatic nerves were severed proximally and stimulated distally by a bipolar silver electrode using supra-maximal square wave pulses of 0.1 ms duration. All isometric measurements were made at an initial muscle length of L0.
Force productions in response to tetanic stimulations (P0) were successively recorded (pulse frequency from 50 to 150 Hz, train duration of 500 ms), at least 1 min was allowed between each contractions. The muscle mass (m) was measured to calculate sP0. Fatigue resistance was then determined after a 5 min rest period. The muscle was stimulated during 500 ms at 100 Hz, every 2 s, for 3 min. The duration corresponding to a force decreased by 50% was noted. After contractile measurements, the animals were killed with an overdose of pentobarbitone. Muscles were then weighed, frozen in liquid nitrogen or in isopentane pre-cooled in liquid nitrogen and stored at -80°C until histology or biochemical analyses.
Mitochondrial respiration and cytosolic enzyme measurements [A] Measurement of OXPHOS activity
The mitochondrial respiration was studied in vitro in saponin-skinned fibers. Briefly, fibers
were separated under a binocular microscope in solution S at 4°C (see below) and permeabilized in solution S with 50 µg/ml of saponin for 30 min. After being placed 10 min in solution R (see below) to wash out adenine nucleotides and creatine phosphate, skinned separated fibers were transferred into a 3 ml water-jacketed oxygraphic cell (Strathkelvin Instruments, Glasgow, UK) equipped with a Clark electrode, as previously described (5) , 20 mM taurine, 0.5 mM DTT, 50 mM potassium-methane sulfonate (160 mM ionic strength), and 20 mM imidazole (pH 7.1). Solution S also contained 5.7 mM Na 2 ATP, 15 mM creatine-phosphate, while solution R contained 5 mM glutamate, 2 mM malate, 3 mM phosphate, and 2 mg/ml FA free bovine serum. After the experiments, fibers were harvested and dried, and respiration rates were expressed as micromoles of O 2 per minute per gram dry weight. Solution R -was similar to solution R without substrates and was used to determined maximal VO 2 rates for different substrates
[B] Measurement of the maximal muscular oxidative capacities
After the determination of the basal respiration rate V 0 , the maximal fiber respiration rate was measured at 22°C in the presence of a saturating (2 mM) ADP concentration as phosphate acceptor and glutamate-malate as mitochondrial substrates (V GM ). The acceptor control ratio was V GM /V 0 and represented the degree of coupling between oxidation and phosphorylation.
[C] Measurement of the respiratory chain complexes When V GM was recorded, electron flow goes through complexes I, II, III, and IV. Then 4 min after this V GM measurement, the complex I was blocked with amytal (2 mM), and then complex II was stimulated with succinate (25 mM). In these conditions, mitochondrial respiration was effected by complexes II, III, and IV (V S ). After that, N,N,N',N'-tetramethyl-pphenylenediamine dihydrochloride (TMPD, 0.5 mM) and ascorbate (0.5 mM) were added as an artificial electron donor to cytochrome C. In these conditions, cytochrome C oxidase (complex IV) was studied as an isolated step of respiratory chain (V TMPD ). The ratios V S /V GM and V TMPD /V GM allow exploration of complexes I, II, and IV.
[D] Measurement of enolase activity
Enolase activity was determined in extracts from frozen cryostat sections using a coupled enzyme assay (35) . For MHC gel electrophoresis, the muscles were extracted on ice for 60 minutes in 4 volumes of extracting buffer (pH 6.5) as previously described (10) . Following centrifugation, the supernatants were diluted 1:1 (v/v) with glycerol and stored at -20 °C. MHC isoforms (MHC-1, MHC-2a, MHC-2x, MHC-2b) were separated on 8% polyacrylamide gels which were made in the Bio-Rad mini-Protean II Dual slab cell system as described previously (1) . The gels were run for 31 hours at a constant voltage of 72 V at 4°C. Following migration, the gels were silver stained. The positions of the different MHC bands were confirmed by Western blotting using antibodies directed against different MHC isoforms. The gels were scanned using a video acquisition system.
Immunostaining and SDS-PAGE

Production and injection of AAV-propeptide for adult myostatin blockade
The myostatin propeptide construct, prepared by PCR amplification of C57BL/6J cDNA, using the primers 5'-CCG CTC GAG ATG ATG CAA AAA CTG CAA ATG-3' and 5'-CCG GGA TCC CTA TTA GTC TCT CCG GGA CCT CTT-3', was introduced into an AAV-2-based vector between the 2 inverted terminal repeats and under the control of the cytomegaly virus promoter using the XhoI and BamHI sites. The AAV myostatin propeptide was produced in human embryonic kidney 293 cells by the triple-transfection method using the calcium phosphate precipitation technique with both the pAAV2 propeptide plasmid, the pXX6 plasmid coding for the adenoviral sequences essential for AAV production, and the pRepCAp plasmid coding for AAV8 capsid. The virus was then purified by 2 cycles of cesium chloride gradient centrifugation and concentrated by dialysis. The final viral preparations were kept in PBS solution at -80°C. The particle titer (number of viral genomes) was determined by a quantitative PCR.
The detailed procedure for intra-arterial injection was previously described (16) . Briefly, anesthetized 2-month-old C57BL/6J wildtype male mice underwent femoral artery and vein isolation of the right hind limb. After clamping the femoral vein and two collaterals, a catheter was introduced into the femoral artery and the AAV preparation (2.5 x 10 12 vg per injection) was injected in a volume of 1 ml per 20 g of body weight at a rate of 100 µl/s. Thereafter, the left hind limb was processed in the same manner and injected with a same volume of PBS. For systemic delivery, 1 x 10 13 vg of AAV2/8-myostatin propeptide was injected into the retro-orbital sinus or with PBS for controls.
RT-qPCR
Total RNA was extracted from frozen muscle after pulverization in liquid nitrogen and from cultured C 2 C 12 cell pellets with the TRIzol® (Invitrogen) extraction protocol. 2.25 µg total RNA were reversely transcribed using the Thermoscript® RT-PCR System (Invitrogen) with random hexamers in 60 µl reaction volume of which we used 4 µl for each subsequent qPCR-reaction and 2 µl of a 1:10 dilution for the 18S reference gene. We used the following oligonucleotide Before sample analysis we had determined for each gene the PCR efficiencies with a standard dilution series (10 0 -10 7 copies/µl), which subsequently enabled us to calculate the copy numbers from the C t values, using the -ΔΔC t method.
Statistical analysis
Data were analyzed using either one-way ANOVA, followed by Tukey post-hoc test, or paired/unpaired Student's t tests. Values are presented as means ± SEM. The significance level was set at p<0.05. 
